Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals
Air France KLM Martinair Cargo (AFKLMP Cargo) and Envirotainer—provider of secure cold-chain solutions for the air transportation of pharmaceuticals—are collaborating on more sustainable air transport of pharmaceuticals, it was revealed in a Jan. 18, 2021 press release.
The companies have been partners for a long time, and each has a strong focus on sustainability. With this announcement, the companies have specified that they will intensify their partnership to strengthen their initiatives for sustainability through collaboration.
AFKLMP Cargo will be implementing in its booking system the new Envirotainer Releye container, which is reported to deliver up to 90% reduction in CO2 emissions compared with other available passive solutions when based on life-cycle analysis. Envirotainer will be investing in Sustainable Aviation Fuel (SAF), which is produced from sustainable feedstock and is claimed to reduce CO2 emissions by up to 85% when compared with conventional jet fuel.
“We are very happy that a close partner of ours since many years keeps delivering top quality service and secures that the pharmaceutical industry, together with us, provides further capacity of latest technology,” said Don Harrison, head of Global Key Accounts, Airlines at Envirotainer, in the press release.
“We really appreciate our long-term partnership with Envirotainer,” added Marcel Kuijn, global head of Pharmaceutical Logistics at AFKLMP Cargo, in the press release. “Sustainability and Pharmaceuticals are among our strategic focus areas. That is why this initiative is of such great importance to us.”
Source: Envirotainer
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.